Merging thoughts II
This article was originally published in The Tan Sheet
Executive Summary
Merger discussions between SmithKline Beecham and Glaxo Wellcome have started up again, the companies announce Jan. 14. Changes in senior management since the last go-around, namely the pending departure of SB CEO Jan Leschly and the possible early retirement of Glaxo CEO Richard Sykes, may help talks progress more smoothly